Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Pharmala Biotech Holdings Inc
C.MDMA
Alternate Symbol(s):
MDXXF
PharmAla Biotech Holdings Inc. is a Canada-based biotechnology company. The Company is focused on the development, manufacture and sales of methylenedioxy methamphetamine (MDMA) and methylenedioxy phenethylamines (MDXX) class molecules in service to the burgeoning clinical research community and growing commercial use cases in select jurisdictions. The Company has three primary business lines...
: the manufacture of MDMA and MDXX class molecules for sale to clinical researchers in both the commercial and academic sphere, the research and development of novel MDXX class compounds which offer unique benefits above and beyond known substances, and the development of novel delivery mechanisms for MDMA and MDXX class compounds. Its research and development unit has completed proof-of-concept research into several IP families, including ALA-002, its lead drug candidate. It works with laboratories across Canada to develop novel processes for the supply of LaNeo MDMA and other MDXX substances.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:MDMA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 26, 2024 8:55am
New Press Release - PharmAla Biotech Signs Sale Agreement with Numinus
LaNeo Product Data submitted for a Clinical Trial in Canada TORONTO, March 26, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA, OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel...
read article.
(86)
•••
Firepoker
X
View Profile
View Bullboard History
Post by
Firepoker
on Mar 22, 2024 8:59am
Utah 1st State to legalize treatment with MDMA
A milestone reached... https://www.sltrib.com/news/2024/03/21/psilocybin-mdma-treatments-could/
(41)
•••
polygraph46
X
View Profile
View Bullboard History
Post by
polygraph46
on Mar 21, 2024 5:06pm
Re: Patent
Excellent commentary on this board with yesterday's news. It truly is good news, and for MDMA, another milestone reached. Patent allowance is not an easy mark, bur nevertheless a very
...more
(86)
•••
Firepoker
X
View Profile
View Bullboard History
Comment by
Firepoker
on Mar 21, 2024 7:39am
RE:RE:Halted
This is a snippet from the news bulletin. “The potential for a drug that could not only assist with psychological trauma, but also neurological damage, could find broad applicability in
...more
(86)
•••
Firepoker
X
View Profile
View Bullboard History
Comment by
Firepoker
on Mar 21, 2024 7:13am
RE:RE:Halted
Yes it protects his intellectual property rights...it is 100% a Pharmala product...and with this new drug line...bypasses the MAPS sales exclusivity in the USA.
(176)
•••
inviolablspirit
X
View Profile
View Bullboard History
Comment by
inviolablspirit
on Mar 20, 2024 10:39pm
RE:Halted
Absolutely fantastic news! I believe this may be the piece of the puzzle needed by Pharmala to form company partnerships. I think Nick needs the patent allowance first before
...more
(3217)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Mar 20, 2024 11:12am
Patent Allowance Granted C.MDMA
TORONTO, March 20, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 20, 2024 10:35am
New Press Release - Canadian Investment Regulatory Organization Trade Resumption - MDMA
VANCOUVER, BC, March 20, 2024 /CNW/ - Trading resumes in:Company: Pharmala Biotech Holdings Inc.CSE Symbol: MDMAAll Issues: YesResumption (ET): 11:00 AMCIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 20, 2024 10:20am
New Press Release - Patent Allowance Granted for P-1 Molecule by US Patent and Trademark Office
Novel MDMA-Like Drug Could Be Used for Numerous Neurological and Psychiatric Indications TORONTO, March 20, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 20, 2024 9:47am
New Press Release - Canadian Investment Regulatory Organization Trading Halt - MDMA
VANCOUVER, BC, March 20, 2024 /CNW/ - The following issues have been halted by CIRO:Company: Pharmala Biotech Holdings Inc.CSE Symbol: MDMAAll Issues: YesReason: Pending NewsHalt Time (ET): 9:36 AMCIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a...
read article.
(41)
•••
polygraph46
X
View Profile
View Bullboard History
Post by
polygraph46
on Mar 20, 2024 9:43am
Halted
We are halted. What's coming down the pipe? pg
(176)
•••
inviolablspirit
X
View Profile
View Bullboard History
Comment by
inviolablspirit
on Mar 19, 2024 1:48pm
RE:RE:RE:Horizens Psychedelics ETF is closing this month
Sorry, my mistake 1.49% of the Horizons ETF fund would be about 950 000 shares of MDMA left to sell at the current price of 15.5 cents. So they are certainly not done selling shares and the
...more
(176)
•••
inviolablspirit
X
View Profile
View Bullboard History
Comment by
inviolablspirit
on Mar 19, 2024 1:42pm
RE:RE:Horizens Psychedelics ETF is closing this month
So at the end of last week the horizons Pscych ETF is now down to 1.49% of MDMA and 2.44% of NUMI. So after today I would think Horizons ETF is probably done selling MDMA as 1.49% is about 147
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 18, 2024 8:55am
New Press Release - Cortexa Leads the World in First Supply of Psilocybin Under the TGA's Authorized Prescriber Scheme
PharmAla now first company to supply both MDMA and Psilocybin into the Australian Market VANCOUVER, British Columbia, March 18, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research...
read article.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
One Property, One Focus on Advancing this Gold Project in Ontario
Options Trading for Retiring: Key Strategies in Balancing Retirement Income